Page last updated: 2024-08-24

trovafloxacin and imipenem, anhydrous

trovafloxacin has been researched along with imipenem, anhydrous in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (55.56)18.2507
2000's2 (22.22)29.6817
2010's2 (22.22)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chu, DT; Katz, L; Plattner, JJ1
Lombardo, F; Obach, RS; Waters, NJ1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Hecht, DW; Osmolski, JR1
Appelbaum, PC; Bajaksouzian, S; Jacobs, MR; Visalli, MA1
Falagas, ME; McDermott, L; Snydman, DR1
Bur, F; Donahue, PE; Luke, DR; Mintz, SJ; Smith, DL; Yellin, AE1
Calvo, A; García, R; Gómez-Lus, ML; Leturia, A; Sevillano, D; Valero, E1
Srinivas, NR1

Reviews

1 review(s) available for trovafloxacin and imipenem, anhydrous

ArticleYear
New directions in antibacterial research.
    Journal of medicinal chemistry, 1996, Sep-27, Volume: 39, Issue:20

    Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacteria; Drug Resistance, Microbial; Molecular Sequence Data; Molecular Structure

1996

Trials

1 trial(s) available for trovafloxacin and imipenem, anhydrous

ArticleYear
Trovafloxacin in the treatment of intra-abdominal infections: results of a double-blind, multicenter comparison with imipenem/cilastatin. Trovafloxacin Surgical Group.
    American journal of surgery, 1998, Volume: 176, Issue:6A Suppl

    Topics: Abdomen; Administration, Oral; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Cilastatin; Clavulanic Acid; Double-Blind Method; Female; Fluoroquinolones; Humans; Imipenem; Injections, Intravenous; Male; Middle Aged; Naphthyridines; Penicillins; Prospective Studies; Protease Inhibitors; Surgical Wound Infection; Thienamycins; Treatment Outcome

1998

Other Studies

7 other study(ies) available for trovafloxacin and imipenem, anhydrous

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Comparison of activities of trovafloxacin (CP-99,219) and five other agents against 585 anaerobes with use of three media.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1996, Volume: 23 Suppl 1

    Topics: Anti-Infective Agents; Bacteria, Anaerobic; Ciprofloxacin; Clindamycin; Culture Media; Drug Resistance, Microbial; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; Imipenem; In Vitro Techniques; Metronidazole; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin

1996
Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rods.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:7

    Topics: Amikacin; Anti-Infective Agents; Ceftazidime; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Gram-Negative Bacteria; Imipenem; Microbial Sensitivity Tests; Naphthyridines; Titrimetry

1997
Effect of pH on in vitro antimicrobial susceptibility of the Bacteroides fragilis group.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:9

    Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteroides fragilis; Ciprofloxacin; Clindamycin; Drug Therapy, Combination; Fluoroquinolones; Hydrogen-Ion Concentration; Imipenem; Meropenem; Microbial Sensitivity Tests; Naphthyridines; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Thienamycins

1997
[Activity of new fluoroquinolones against clinical isolates of Acinetobacter baumannii].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2001, Volume: 14, Issue:4

    Topics: Acinetobacter; Acinetobacter Infections; Ampicillin; Anti-Infective Agents; Aza Compounds; Cefepime; Cephalosporins; Ciprofloxacin; Colistin; Fluoroquinolones; Gatifloxacin; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Moxifloxacin; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Opportunistic Infections; Quinolines; Sulbactam; Thienamycins

2001
Interspecies scaling of excretory amounts using allometry - retrospective analysis with rifapentine, aztreonam, carumonam, pefloxacin, miloxacin, trovafloxacin, doripenem, imipenem, cefozopran, ceftazidime, linezolid for urinary excretion and rifapentine,
    Xenobiotica; the fate of foreign compounds in biological systems, 2016, Volume: 46, Issue:9

    Topics: Animals; Anti-Bacterial Agents; Aztreonam; Carbapenems; Cefozopran; Ceftazidime; Cephalosporins; Doripenem; Feces; Fluoroquinolones; Heterocyclic Compounds, 3-Ring; Humans; Imipenem; Linezolid; Naphthyridines; Oxazines; Oxolinic Acid; Pefloxacin; Piperazines; Pyridones; Retrospective Studies; Rifampin

2016